NAD on breast enhancement tablets
This article was originally published in The Tan Sheet
Ad watchdog group recommends Dream Products discontinue claims its Breast Enhancer Tablets offer an alternative to surgery or push-up bras, recent case report states. Wellquest International challenged Dream's print, Internet ad claims, such as "Larger shapelier breasts...without surgery" and "Clinically formulated to increase your bust size," describing claims as "false, misleading and unsubstantiated." Wellquest also asserted Dream had not provided clinical research on Breast Enhancer's exact formulation, which includes saw palmetto, wild yam, damiana, dong quai, fenugreek, black cohosh, blessed thistle and rice flour. CBBB division agrees, noting Dream's performance, health-related claims "were not supported by competent and scientific evidence." Dream says it will modify future ads...
You may also be interested in...
The US FDA wants to expand the availability of surgical apparel – including gowns, hoods and examination gloves – for health care professionals to use for the duration of the COVID-19 public health crisis. That means the agency will “not object” to the use of gowns and gloves providing low-to-minimal protection, as long as they do not create an undue risk to patients or users.
Efficacy seen in reducing hospitalization in high-risk heart failure patients, but not in reducing the risk of cardiovascular death. Analysts say this portends a more niche opportunity for vericiguat.
The US FDA has issued an emergency use authorization for a Battelle decontamination system to clean N95 masks, which are currently facing a shortage due to the COVID-19 pandemic. The company says it can clean up to 80,000 respirator masks a day from participating health care providers.